Molecular Markers of Clonality, Lineage, Differentiation, and Translocation in B Cell Neoplasms

  • Stanley J. Korsmeyer
  • Ajay Bakhshi
  • John J. Wright
  • Winfried C. Graninger
  • Carolyn Felix
  • Masao Seto
Part of the NATO ASI Series book series (NSSA, volume 123)


The demonstration that distinct types of lymphoid neoplasms could be assigned to stages of B or T cell development provided great insights into the biology of these malignancies1,2. Historically this has been approached by utilizing cell surface markers associated with various developmental stages of B or T cell maturation. Despite a large number of lineage-associated cell surface markers, it is still frequently impossible to conclusively classify a lymphoid neoplasm as B or T cell in origin. This is often due to the admixture of large numbers of nonneoplastic cells with the neoplastic cells in a lymphomatous tissue. Alternatively, other malignancies may be at a stage of differentiation prior to the expression of any lineage-restricted cell surface antigen. Moreover, the determination of clonality in lymphoid neoplasms has for all practical purposes been limited to the mature B cell malignancies that display the presence of but one light (L)-chain isotype, κ or λ. The DNA rearrangements which assemble the gene subsegments for antigen-specific receptors in B cells as well as T cells serve as molecular markers which are unique to individual neoplasms. The rearranging determinants have made an enormous contribution to refining the diagnosis and understanding the pathogenesis of lymphoid neoplasms.


Chronic Lymphocytic Leukemia Lymphoid Neoplasm Breakpoint Cluster Region Diffuse Large Cell Lymphoma Follicular Lymphomas7 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aisenberg, A. C. N. Engl. J. Med. 304, 331–336 (1978).CrossRefGoogle Scholar
  2. 2.
    Rudders, R. A., Ahl, E. T., Jr. & DeLellis R. A. Cancer 47, 1329–1335 (1981).CrossRefGoogle Scholar
  3. 3.
    Arnold, A., Cossman, J., Bakhshi, A., Jaffe, E. S., Waldmann, T. A. & Korsmeyer, S. J. N. Engl. J. Med. 309, 1593–1599 (1983).CrossRefGoogle Scholar
  4. 4.
    Waldmann, T. A., Davis, M. M., Bongiovanni, K. F. & Korsmeyer S. J. N. Engl. J. Med. 313, 776–783 (1985).CrossRefGoogle Scholar
  5. 5.
    Taub, R. et al. Proc. Natl. Acad. Sci. USA 79, 7837–7842 (1982).CrossRefGoogle Scholar
  6. 6.
    Nishikura, K., Ar-Rushdi, A., Erickson, J., Watt, R., Rovera, G. & Croce, C. M. Proc. Natl. Acad. Sci. USA 80, 4822–4827 (1983).CrossRefGoogle Scholar
  7. 7.
    Bakhshi, A. et al. Cell 41, 899–906 (1985).CrossRefGoogle Scholar
  8. 8.
    Korsmeyer, S. J., Hieter, P. A., Sharrow, S. O., Goldmann, C. K., Leder, P. & Waldmann, T. A. J. Exp. Med. 156, 975–985 (1982).CrossRefGoogle Scholar
  9. 9.
    Cleary, M. I., Warnke, R. & Sklar, J. N. Engl. J. Med. 310, 477–482 (1984).CrossRefGoogle Scholar
  10. 10.
    Hieter, P. A., Korsmeyer, S. J., Waldmann, T. A. & Leder P. Nature 390, 368–372 (1981).CrossRefGoogle Scholar
  11. 11.
    Korsmeyer, S. J., Hieter, P. A., Ravetch, J. V., Poplack, D. G., Waldmann, T. A. & Leder P. Proc. Natl. Acad. Sci. USA 78, 7096–7100 (1981).CrossRefGoogle Scholar
  12. 12.
    Siminovitch, K. A., Bakhshi, A., Goldman, P. & Korsmeyer, S. J. Nature 316, 260–262 (1985).CrossRefGoogle Scholar
  13. 13.
    Korsmeyer, S. J. et al. J. Clin. Invest. 71, 301–313 (1983).CrossRefGoogle Scholar
  14. 14.
    Nadler, L. M. et al. J. Clin. Invest. 72, 332–340 (1984).CrossRefGoogle Scholar
  15. 15.
    Wright, J. J. et al. N. Engl. J. Med. (submitted).Google Scholar
  16. 16.
    Nadler, L. M. et al. J. Immunol. 131, 244–250 (1983).Google Scholar
  17. 17.
    Nadler, L. M., Ritz, J., Hardy, R., Pesando, J. M. & Schlossman, S. F. J. Clin. Invest. 67, 134–141 (1981).CrossRefGoogle Scholar
  18. 18.
    Yanagi, Y., Yoshikai, Y., Leggett, K., Clark, S. P., Aleksander, I. & Mak, T. W. Nature 308, 145–149 (1984).CrossRefGoogle Scholar
  19. 19.
    Hedrick, S. M., Cohen, D. I., Nielson, E. A. & Davis, M. M. Nature 308, 149–153 (1984).CrossRefGoogle Scholar
  20. 20.
    Chien, Y.-H., Becker, D. M., Lindsten, T., Okamuras, M., Cohen, D. I. & Davis, M. M. Nature 312, 31–35 (1984).CrossRefGoogle Scholar
  21. 21.
    Saito, H., Kranz, D. H., Takagaki, Y., Hayday, A. C., Eisen, H. N. & Tonegawa, S. Nature 312, 36–40 (1984).CrossRefGoogle Scholar
  22. 22.
    Bakhshi, A. et al. N. Engl. J. Med. 309, 826–831 (1983).CrossRefGoogle Scholar
  23. 23.
    Ford, A. M., Molgaard, H. V., Greaves, M. F. & Gould, H. J. EMBO J. 2, 997–1001 (1983).Google Scholar
  24. 24.
    Korsmeyer, S. J. et al. Proc. Natl. Acad. Sci. USA 80, 4522–4526 (1983).CrossRefGoogle Scholar
  25. 25.
    Rowley, J. D. & Testa, A., Jr. Adv. Cancer Res. 36, 103–148 (1982).CrossRefGoogle Scholar
  26. 26.
    Yunis, J. J. Science 221, 227–236 (1983).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Stanley J. Korsmeyer
    • 1
  • Ajay Bakhshi
    • 1
  • John J. Wright
    • 1
  • Winfried C. Graninger
    • 1
  • Carolyn Felix
    • 1
  • Masao Seto
    • 1
  1. 1.Metabolism Branch, National Cancer InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations